Nasal production of IL-26 involving T cells in smokers with and without chronic obstructive pulmonary disease
In the nasal cavity, IL-26 can be produced by local T cells. This IL-26 reflects bronchoalveolar pathology and clinical symptoms, thereby constituting an accessible target with potential for clinically relevant endotyping in COPD.
Authors
- Eduardo I. Cardenas (ORCID: https://orcid.org/0000-0001-5973-5675)
- Julia Arebro (ORCID: https://orcid.org/0000-0002-2584-0941)
- Karlhans Fru
- Sven Nyrén (ORCID: https://orcid.org/0000-0003-3586-8785)
- Anders Lindén (ORCID: https://orcid.org/0000-0003-1258-2928)
- Apostolos Bossios (ORCID: https://orcid.org/0000-0002-0494-2690)
- Nikolaos Pournaras (ORCID: https://orcid.org/0000-0002-9693-3838)
- Patricia Ramos‐Ramírez (ORCID: https://orcid.org/0000-0001-5546-277X)
- Bettina Brundin
- Pär Stjärne
- Reza Karimi (ORCID: https://orcid.org/0000-0002-3085-3480)
- Magnus Sköld
- Elga Bandeira
Institutions
- Karolinska University Hospital (SE)
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.jaci.2025.03.017
- Citations
- 1
- Primary Topic
- Pediatric health and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.52